Nov 08, 2022:
SPAC Revival: AUM Pursues $400M Deal to Develop Cancer Pipeline
Read more..
Oct 21, 2022:
SPAC in fashion: Cancer-focused Aum is latest biotech to use blank check route
Read more..
Oct 20, 2022:
AUM Biosciences to list on Nasdaq via SPAC merger at US$400m pre-money valuation
Read more..
Oct 20, 2022:
Playboy, digital health, electric vehicles and now cancer drugs: A mountainous SPAC journey
Read more..
Aug 19, 2022:
FDA Weekly Review: Daewoong, Novavax, Preceptis and More
Read more..
May 6, 2022:
AUM Biosciences inks clinical trial collaboration with Merck for colorectal cancer
Read more..
Jan 26, 2022: Tools for adapting cancer trials during the COVID-19 pandemic: an interview with Harish Dave
Jan 11, 2022: Asian Biotech Clinical Trial Demand Moves to the West
Dec 10, 2021: Vishal Doshi wants to turn cancer into a manageable lifestyle disease
Nov 18, 2021: Singapore AUM Biosciences sees opportunities in Asia and India
Nov 1, 2021: Indian oncology therapeutics market is at the cusp of innovation
Oct 25, 2021: Mind Your Business: AUM Biosciences raises US$27m in Series A funding – What’s in the pipelines
Oct 19, 2021:
Aum Biosciences closes $27M series A financing for targeted cancer drugs
Oct 13, 2021: AUM Biosciences raises $27m
Oct 13, 2021: AUM Biosciences closes $27Million series-A funding round with Everlife, SGI as top investors
Oct 13, 2021: Aum bags $27M to hit cancer targets pursued by Bayer, Roche
Oct 12, 2021: Cancer treatment startup AUM Biosciences raises US$27m in Series A funding
Oct 12, 2021: Biotech startup AUM Biosciences raises $27 mn from Everlife and SGI